KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Shares Issued (2016 - 2026)

Staar Surgical (STAA) has disclosed Shares Issued for 17 consecutive years, with $114000.0 as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Shares Issued rose 185.0% year-over-year to $114000.0, compared with a TTM value of $3.5 million through Jan 2026, down 53.12%, and an annual FY2026 reading of $3.5 million, down 53.12% over the prior year.
  • Shares Issued was $114000.0 for Q1 2026 at Staar Surgical, down from $3.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $7.3 million in Q3 2023 and bottomed at $11000.0 in Q2 2025.
  • Average Shares Issued over 5 years is $1.8 million, with a median of $720500.0 recorded in 2022.
  • The sharpest move saw Shares Issued surged 906.43% in 2024, then crashed 97.04% in 2025.
  • Year by year, Shares Issued stood at $243000.0 in 2022, then soared by 67.9% to $408000.0 in 2023, then plummeted by 90.2% to $40000.0 in 2024, then skyrocketed by 7310.0% to $3.0 million in 2025, then plummeted by 96.15% to $114000.0 in 2026.
  • Business Quant data shows Shares Issued for STAA at $114000.0 in Q1 2026, $3.0 million in Q3 2025, and $11000.0 in Q2 2025.